Cloned (Comment) | Organism |
---|---|
recombinant expression of the C-terminally His6-tagged CdgH periplasmic portion (residues 46-491) including the tandem PBPb-I and PBPb-II domains of the enzyme | Vibrio cholerae serotype O1 |
Crystallization (Comment) | Organism |
---|---|
purified recombinant periplasmic portion (residues 46-491, which includes the tandem PBPb-I and PBPb-II domains) of C-terminally His6-tagged CdgH, X-ray diffraction structure determination and analysis at 2.6 A resolution | Vibrio cholerae serotype O1 |
Protein Variants | Comment | Organism |
---|---|---|
additional information | ITC analysis of interactions between different amino acids and the periplasmic portion of CdgH with different truncations and mutants, overview | Vibrio cholerae serotype O1 |
Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|
membrane | both PBPb-I domains are membrane-distal with the pockets oriented relatively upwards, and both PBPb-II domains are membrane-proximal with the pockets relatively downwards. The two C-terminal alpha8' helices serving as pre-transmembrane sequences at the membrane-proximal end of the structure locate adjacent to each one and can be connected to the subsequent transmembrane helices | Vibrio cholerae serotype O1 | 16020 | - |
additional information | the periplasmic portion comprises residues 46-491. The periplasmic portion of CdgH forms a dimer in solution, L-arginine binding causes conformational changes of the dimer, structure overview. The architecture of the periplasmic tandem PBPb domains of CdgH may undergo a conformational changes from loose dimer to compact dimer | Vibrio cholerae serotype O1 | - |
- |
Molecular Weight [Da] | Molecular Weight Maximum [Da] | Comment | Organism |
---|---|---|---|
22300 | - |
monomeric PBPbI domain, analytical ultracentrifugation | Vibrio cholerae serotype O1 |
23100 | - |
monomeric PBPbI domain, sequence calculation | Vibrio cholerae serotype O1 |
87300 | - |
recombinant dimeric periplasmic portion of enzyme CdgH, analytical ultracentrifugation | Vibrio cholerae serotype O1 |
101600 | - |
dimeric periplasmic portion of enzyme CdgH, sequence calculation | Vibrio cholerae serotype O1 |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
2 GTP | Vibrio cholerae serotype O1 | - |
2 diphosphate + cyclic di-3',5'-guanylate | - |
? | |
2 GTP | Vibrio cholerae serotype O1 El Tor Inaba N16961 | - |
2 diphosphate + cyclic di-3',5'-guanylate | - |
? | |
2 GTP | Vibrio cholerae serotype O1 ATCC 39315 | - |
2 diphosphate + cyclic di-3',5'-guanylate | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Vibrio cholerae serotype O1 | Q9KT38 | - |
- |
Vibrio cholerae serotype O1 ATCC 39315 | Q9KT38 | - |
- |
Vibrio cholerae serotype O1 El Tor Inaba N16961 | Q9KT38 | - |
- |
Purification (Comment) | Organism |
---|---|
recombinant C-terminally His6-tagged CdgH periplasmic portion | Vibrio cholerae serotype O1 |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
2 GTP | - |
Vibrio cholerae serotype O1 | 2 diphosphate + cyclic di-3',5'-guanylate | - |
? | |
2 GTP | - |
Vibrio cholerae serotype O1 El Tor Inaba N16961 | 2 diphosphate + cyclic di-3',5'-guanylate | - |
? | |
2 GTP | - |
Vibrio cholerae serotype O1 ATCC 39315 | 2 diphosphate + cyclic di-3',5'-guanylate | - |
? |
Subunits | Comment | Organism |
---|---|---|
More | the periplasmic portion of CdgH forms a type I homodimer in solution which undergoes conformational changes upon L-arginine binding. The dimerization mode requires both tandem PBPb domains. Homodimerization leads to alignment of the two GGDEF domains, resulting in 2fold symmetry that enables the enzyme to catalyze c-diGMP synthesis | Vibrio cholerae serotype O1 |
Synonyms | Comment | Organism |
---|---|---|
CdgH | - |
Vibrio cholerae serotype O1 |
DGC | - |
Vibrio cholerae serotype O1 |
GGDEF domain-containing protein | UniProt | Vibrio cholerae serotype O1 |
VC_1067 | - |
Vibrio cholerae serotype O1 |
General Information | Comment | Organism |
---|---|---|
evolution | proteins with a conserved C-terminal GGDEF domain act as DGCs, whereas proteins containing EAL or HD-GYP domains act as c-di-GMP-specific phosphodiesterases (PDEs). Vibrio cholerae genome typically encodes 31 proteins with a GGDEF domain | Vibrio cholerae serotype O1 |
additional information | the periplasmic portion of CdgH forms a homodimer in solution which undergoes conformational changes upon L-arginine binding. Homodimerization leads to alignment of the two GGDEF domains, resulting in 2fold symmetry that enables the enzyme to catalyze c-diGMP synthesis. Both tandem PBPb domains of CdgH contain a typical interlobe ligand-binding structural architecture. PBPb-I and -II domains have different amino acid binding specificity. The PBPb-I domain is primarily an L-arginine/L-lysine/L-ornithine-binding domain, whereas the PBPb-II domain exhibits a preference for L-glutamine and L-histidine, binding site structures, overview. Comparison of the CdgH PBPb-I domain with other amino acid-binding proteins | Vibrio cholerae serotype O1 |
physiological function | 3',5'-cyclic diguanylate monophosphate (c-di-GMP) is a ubiquitous secondary messenger that plays a key role in response regulation and lifestyle conventions of pathogenic bacteria, including Vibrio cholerae. Increases in c-di-GMP levels induce increased expression of various factors necessary for the establishment and maintenance of biofilm communities, whereas decreased levels usually lead to enhanced expression of virulence and motility factors related to biofilm degradation. C-di-GMP is synthesized from guanosine triphosphate by diguanylate cyclase (DGC) enzymes | Vibrio cholerae serotype O1 |